Umeå-based Medicvent has been awarded a new prestigious assignment to deliver central systems for waste gas/diathermy and its unique double mask system used in anesthesia to Högsbo Regional Hospital, which will be inaugurated in Gothenburg in 2024. "Things are going well both in Sweden and abroad. We also have a couple of new markets that we are hoping to supply", says CEO Erik Lindström.
In June, Lipigon Pharmaceuticals signed a development and licensing agreement worth nearly SEK 1 billion. Today, the Umeå-based company has relocated to a newly renovated 250 square meter facility tailored to their needs. Lipigon's CEO, Stefan K. Nilsson, views these achievements as "pivotal strides in the company's ongoing journey of growth and innovation."
Technology consulting company Prevas is looking to hire a Business Unit Manager for its new offices in the city. "We know that there is huge potential in Umeå, both within MedTech and life science in general", says Robert Tönhard, Life Science Director at Prevas.
The AstraZeneca Exchange Nordic mentorship program provides expert advice to Nordic life science startups and entrepreneurs. For Umeå Biotech Incubator (UBI) the program has proven to be an invaluable tool for the startups it coaches - offering a range of advice from market and needs analysis to more specific technical questions.
Thomas Busch has extensive experience in the life science industry. Now he's appointed new Chairman of the Board at HiloProbe.
Umeå-based Lipigon Pharmaceuticals is celebrating the signing of a development and license agreement for its clinical-stage drug candidate Lipisense® with Leaderna Therapeutics worth an estimated USD 91 million.
Umeå University has in collaboration with HiloProbe AB completed the first part of a new clinical study of its ColoNode biomarker test, which provides further important evidence for the product ColoNode's benefits and usefulness in colon cancer.
Umeå Biotech Incubator has been granted SEK 14 million for the ERDF project "Life science city", which will further develop the life science industry in the region.
He has been a vital part of Umeå Biotech Incubator (UBI) since its inception in 2003. But now, after 42 years of service in the biotech industry, it is time for respected research engineer Assar Bäckman to retire. “My work has been hugely varied, and over the years I have learned a great deal. I usually have an emergency solution to most things if needed”, says Assar.
Experienced business coach Peter Jacobsson will now lead Umeå Biotech Incubator until a permanent replacement is appointed.
The Umeå Biotech Incubator-backed ‘Shades of Green’ project, developed by Boreal Orchards, has created a moss that can be used on buildings, infrastructure and for the regeneration of nature. Now founder Daniel Pacurar is collaborating on a new development project with RISE Processum AB and Ecohelix to maximize moss establishment with the help of by-products from the paper pulp industry.
Jennie Ekbeck, CEO of Umeå Biotech Incubator, has been awarded an honorary doctorate for 2023 at the Faculty of Science and Technology at Umeå University. “I want research to benefit people, that is my driving force,” she says.
Umeå Biotech Incubator (UBI) is one of Sweden’s state-of-the-art business incubators within the life sciences. We help researchers to use their data to the benefit of patients and citizens, improving their health. We support and train entrepreneurs in the fields of pharmaceuticals, diagnostics and medical engineering, and act as a bridge between academia, medicine and the business community.
Tvistevägen 48C
907 36 Umeå
Sweden